The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Alpha-2 Antiplasmin testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Alpha-2 Antiplasmin testing closer to the patient, creating additional opportunities and challenges for suppliers.<p>This report presents a detailed analysis of the Alpha-2 Antiplasmin testing market in the US, Europe France, Germany, Italy, Spain, UK and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume forecasts by country and market segment.</p><p>The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies... Research Beam Model: Research Beam Product ID: 14726 2800 USD New
2014 Analysis of the Alpha-2 Antiplasmin Testing Market:US, Europe France, Germany, Italy, Spain, UK, Japan--Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape
 
 

2014 Analysis of the Alpha-2 Antiplasmin Testing Market:US, Europe France, Germany, Italy, Spain, UK, Japan--Emerging Opportunities, Country Forecasts, Innovative Technologies, Competitive Landscape

  • Category : Diagnostic and Biotech
  • Published On : November   2013
  • Pages : 0
  • Publisher : VPGMarketResearch.com
 
 
 

Complete report $3,850.  DataPack test volumes, sales forecasts, supplier shares $2,500.



The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and Alpha-2 Antiplasmin testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the Alpha-2 Antiplasmin testing closer to the patient, creating additional opportunities and challenges for suppliers.



This report presents a detailed analysis of the Alpha-2 Antiplasmin testing market in the US, Europe France, Germany, Italy, Spain, UK and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume forecasts by country and market segment.



The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.



Contains 195 pages and 8 tables


../toc/Coagulatiolpha-2.pdf
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 
REQUEST SAMPLE    ASK FOR DISCOUNT